Rachel Klemovitch, Assistant Editor05.30.24
MedTech Innovator, the world’s largest accelerator of medical technology companies, announced which 20 medtech companies will participate in its fifth annual Asia Pacific Accelerator program.
Fredrik Nyberg, Managing Director, MedTech Innovator Asia Pacific, said: “We are delighted to announce this year’s Asia Pacific cohort of companies, representing ten countries and a broad range of technologies and cutting-edge innovations. We look forward to working with our partners to support this year’s cohort and to help them advance their technologies and transform the lives of patients not only in the region but potentially worldwide.”
MedTech Innovator Asia Pacific unites startup companies with investors, business leaders, and allied service professionals in the medtech industry to help drive commercialization in the region. Companies will also compete for up to $ 300,000 in cash prizes and awards.
Over 400 companies applied for the Asia Pacific program this year; 60 companies were invited to pitch, 20 of which were named to the 2024 cohort.
The Asia Pacific Accelerator 2024 Cohort will join the MedTech Innovator 2024 and the BioTools Cohorts at the invitation-only Innovator Summit 2024 on June 12-13 in San Francisco. This event connects the leadership teams from the latest cohorts with MTI’s partners, alumni, and other industry leaders.
Fredrik Nyberg, Managing Director, MedTech Innovator Asia Pacific, said: “We are delighted to announce this year’s Asia Pacific cohort of companies, representing ten countries and a broad range of technologies and cutting-edge innovations. We look forward to working with our partners to support this year’s cohort and to help them advance their technologies and transform the lives of patients not only in the region but potentially worldwide.”
MedTech Innovator Asia Pacific unites startup companies with investors, business leaders, and allied service professionals in the medtech industry to help drive commercialization in the region. Companies will also compete for up to $ 300,000 in cash prizes and awards.
The 2024 MedTech Innovator Asia Pacific Accelerator Companies
- Alfaleus Technology, Hyderabad, India
- APrevent, Taipei, Taiwan
- ArmasTec, Singapore
- Ausmed Global, Hong Kong
- CancerFree Biotech, Taipei City, Taiwan and the United States
- Endovision, Hong Kong
- Gyder Surgical, California, United States
- Hada MedTech, Ontario, Canada
- INOPASE, Tokyo
- InterMag, Seoul, South Korea
- KA Imaging, Ontario, Canada
- Nanotis, Tokyo
- Niramai Health Analytix, Bengaluru, India
- Padmaseetha Technologies, Chennai, India
- Progressive NEURO, Nebraska, United States
- Promedius, Seoul, South Korea
- Qritive, Singapore
- RNT Health Insights, Chandigarh, India
- Sydney Heart Valve, Sydney, Australia
- Vinbrain Joint Stock Company, Hanoi, Vietnam
Over 400 companies applied for the Asia Pacific program this year; 60 companies were invited to pitch, 20 of which were named to the 2024 cohort.
The Asia Pacific Accelerator 2024 Cohort will join the MedTech Innovator 2024 and the BioTools Cohorts at the invitation-only Innovator Summit 2024 on June 12-13 in San Francisco. This event connects the leadership teams from the latest cohorts with MTI’s partners, alumni, and other industry leaders.